New Research: Two Potential Treatments for Dry Macular Degeneration and Geographic Atrophy

One of the most significant challenges facing eye and vision researchers is developing an effective treatment for dry age-related macular degeneration (AMD). Although there are a number of well-regarded FDA-approved drug treatments for wet AMD, the key to effective dry AMD treatment continues to be elusive. Current treatments for dry AMD include a number of … Continued

Can a New Type of Blood Test Identify Macular Degeneration Much Earlier? New Research Says Yes

New research led by the AMD Center of Excellence at Harvard Medical School, the University of Coimbra, Portugal, and Brigham and Women’s Hospital has used an emerging field of study, called “metabolomics” (explained below), to test patients’ blood and identify blood profiles that are associated with age-related macular degeneration (AMD). According to study co-author Joan … Continued

During Healthy Aging Month, Learn More About Older Adult Eye Health and Low Vision from the National Eye Institute

According to the United States National Eye Institute, “Older adults are at higher risk for certain eye diseases and conditions, including age-related macular degeneration, cataract, diabetic eye disease, glaucoma, dry eye, and low vision. Eye diseases often have no early symptoms, but can be detected during a comprehensive dilated eye exam.” “More than 40 million … Continued

The FDA Officially Cracks Down on Stem Cell Clinics Offering Unproven and Dangerous Treatments

On Monday, August 28, 2017, Scott Gottlieb, M.D., Commissioner of the United States Food and Drug Administration (FDA), announced a crackdown on stem cell clinics offering unproven and potentially dangerous treatments. Commissioner Gottlieb stated that he “will not allow deceitful actors to take advantage of vulnerable patients by purporting to have treatments or cures for … Continued

A Class-Action Lawsuit Against CVS Yields a Decision: Not All Eye Health and Macular Degeneration Supplements Are Equally Effective

Many VisionAware readers write to us, inquiring about the effectiveness of supplements for treating age-related macular degeneration (AMD). Many readers also request clarification of the claims made by companies that produce a now-staggering array of eye health supplements: Do these supplements cure AMD? Do they slow its progression? Can they prevent it from developing? Do … Continued

Readers Beware: Are All Clinical Trials Legitimate? Learn What to Look for and How to Protect Yourself

Of all the eye research developments reported on the VisionAware blog, it is stem cell research for eye disease that generates the most inquiries from our readers. Many readers request information about stem cells, assuming that this is an established and widely-performed treatment for eye disease; others ask for help in finding a doctor who … Continued

The Reality and Costs of Gene Therapy for Eye Disease: Who Will (or Can) Pay?

As our readers know, VisionAware is committed to providing current and reliable information about eye and vision research that is relevant to adults and older adults, many of whom experience late-life vision loss resulting in low vision. During the past several years, gene therapy has gained traction and offers promise for treating (but not yet … Continued

Researchers Continue to Explore the Potential of Human Echolocation and Acoustics for People with Vision Loss

Vision rehabilitation professionals, including Orientation and Mobility Specialists, Vision Rehabilitation Therapists, and Low Vision Therapists, have long been aware of the need to incorporate sensory input, including echolocation, in their instructional programs. Human echolocation describes the ability of humans to detect objects in their environments by sensing reflected sound waves from those objects. Now it … Continued

New Research: A Potential Eye Drop Treatment Could Take the Place of Injectable Drugs for Wet Macular Degeneration

Currently, there are a number of treatments for wet age-related macular degeneration, including the drugs Lucentis, Eylea, and Avastin, administered by injection with a very small needle directly into the eye after the surface has been numbed (also called “intra-vitreous injection”). From a patient’s point of view, however, the “gold standard” for treatment would be … Continued

Treating Macular Degeneration with Gene Therapy: New Research Shows Promise but Also Has Limitations

Currently, there are a number of treatments for wet age-related macular degeneration, including the drugs Lucentis, Eylea, and Avastin, administered by injection with a very small needle directly into the eye after the surface has been numbed (also called “intra-vitreous injection”). There are also a number of treatments that have proven to be inconclusive or … Continued